Prediction: Lilly Stock Will Soar on Access Gains by 2026
A new era of obesity and diabetes treatment access could lift Lilly stock. This article breaks down how an oral GLP-1...
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
16,593 articlesA new era of obesity and diabetes treatment access could lift Lilly stock. This article breaks down how an oral GLP-1...
SpaceX stock has swung wildly since its debut, raising a simple question for every investor: is spacex stock: $150? a...
As July unfolds, investors are eyeing three powerful nuclear energy stocks as policy momentum and grid demand bolster...
META faces a rough patch after a sharp pullback, but analysts say a credible case for upside exists as AI monetizatio...
Eli Lilly's blockbuster first quarter puts the spotlight on a possible stock split as its high-priced shares approach...
Federal agencies are deploying Anthropic’s Mythos to hunt bugs in critical code, a move that broadens AI’s role in na...
U.S. stocks pulled back after signals that a ceasefire may be unraveling, lifting oil and turning traders toward safe...
The Nasdaq 100 ETF is seeing its busiest month in years as traders chase SpaceX exposure, aided by new weighting rule...
A senior strategist has a bold projection for the S&P 500, arguing the index could reach 8,500 by end-2027 as a geopo...
Rocket Lab faces a watershed moment as it logs another quarter of rising revenue and a multi-billion backlog while we...
Intel’s stock whipsawed after a dramatic breakout, triggering a deeper look at whether the move can sustain amid AI d...
A zero-premium Medicare Advantage plan can suddenly require steep out-of-network costs when a preferred surgeon isn’t...